Loss of CD45 cell surface expression in canine T-zone lymphoma results from reduced gene expression.

[1]  L. Marconato,et al.  Canine small clear cell/T-zone lymphoma: clinical presentation and outcome in a retrospective case series. , 2016, Veterinary and comparative oncology.

[2]  L. Aresu,et al.  Flow-cytometric detection of phenotypic aberrancies in canine small clear cell lymphoma. , 2015, Veterinary and comparative oncology.

[3]  S. Comazzi,et al.  Peripheral blood abnormalities and bone marrow infiltration in canine large B-cell lymphoma: is there a link? , 2015, Veterinary and comparative oncology.

[4]  C. Mullighan,et al.  Genomics in acute lymphoblastic leukaemia: insights and treatment implications , 2015, Nature Reviews Clinical Oncology.

[5]  Dongsheng Xu,et al.  Leukocyte common antigen (CD45) negative follicular lymphoma, a rare immunophenotypic presentation. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[6]  J. Oh,et al.  Copy number variability analysis of pharmacogenes in patients with lymphoma, leukemia, hepatocellular, and lung carcinoma using The Cancer Genome Atlas data , 2015, Pharmacogenetics & Genomics.

[7]  H. Tsujimoto,et al.  Differential expression of CD45 isoforms in canine leukocytes. , 2014, Veterinary immunology and immunopathology.

[8]  Paul R. Avery,et al.  Canine T‐Zone Lymphoma: Unique Immunophenotypic Features, Outcome, and Population Characteristics , 2014, Journal of veterinary internal medicine.

[9]  L. Aresu,et al.  The role of vascular endothelial growth factor and matrix metalloproteinases in canine lymphoma: in vivo and in vitro study , 2013, BMC Veterinary Research.

[10]  P. Gaulard,et al.  Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type. , 2010, Blood.

[11]  L. Baum,et al.  CD45-Mediated Fodrin Cleavage during Galectin-1 T Cell Death Promotes Phagocytic Clearance of Dying Cells1 , 2009, The Journal of Immunology.

[12]  S. Comazzi,et al.  ZAP-70 and Syk expression in canine lymphoid cells and preliminary results on leukaemia cases. , 2009, Veterinary immunology and immunopathology.

[13]  J. Bernier,et al.  Involvement of tyrosine phosphatase CD45 in apoptosis , 2009, Apoptosis.

[14]  Paul R. Avery,et al.  Canine lymphoproliferative disease characterized by lymphocytosis: immunophenotypic markers of prognosis. , 2008, Journal of veterinary internal medicine.

[15]  M. Mazzilli,et al.  Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry. , 2008, Veterinary immunology and immunopathology.

[16]  P. Moore,et al.  Canine Indolent Nodular Lymphoma , 2006, Veterinary pathology.

[17]  M. Gelain,et al.  Flow cytometric patterns in blood from dogs with non-neoplastic and neoplastic hematologic diseases using double labeling for CD18 and CD45. , 2006, Veterinary clinical pathology.

[18]  Santhosh K. P. Kumar,et al.  CD45 expression by bone marrow plasma cells in multiple myeloma: clinical and biological correlations , 2005, Leukemia.

[19]  S. Whittaker,et al.  Genetic alterations in primary cutaneous CD30+ anaplastic large cell lymphoma , 2003, Genes, chromosomes & cancer.

[20]  B. Schraven,et al.  Apoptosis Mediated Through CD45 Is Independent of Its Phosphatase Activity and Association with Leukocyte Phosphatase-Associated Phosphoprotein1 , 2002, The Journal of Immunology.

[21]  P. Felman,et al.  Canine T-cell Lymphomas: A Morphological, Immunological, and Clinical Study of 46 New Cases , 2002, Veterinary pathology.

[22]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[23]  J. Harbott,et al.  Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia , 1998, Annals of Hematology.

[24]  N. Gonchoroff,et al.  Extramedullary granulopoiesis mimicking recurrent lymphoma after prolonged administration of human recombinant granulocyte colony-stimulating factor , 1998, Annals of Hematology.

[25]  P. Hugo,et al.  CD4+ CD8+ thymocytes are preferentially induced to die following CD45 cross-linking, through a novel apoptotic pathway. , 1997, Journal of immunology.

[26]  D. Alexander,et al.  CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation , 1996, The Journal of experimental medicine.

[27]  N. Harris,et al.  Hodgkin's disease presenting as a solitary bone tumor: A report of four cases and review of the literature , 1996, Cancer.

[28]  T. Mak,et al.  Normal B lymphocyte development but impaired T cell maturation in CD45-Exon6 protein tyrosine phosphatase-deficient mice , 1993, Cell.

[29]  Matthew L. Thomas,et al.  Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation , 1989, Cell.